MIDLAND EXPLORATION INC (MD.CA) Fundamental Analysis & Valuation

TSX-V:MD • CA59751U1003

Current stock price

0.43 CAD
+0.02 (+4.88%)
Last:

This MD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MD.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MD has reported negative net income.
  • MD had a negative operating cash flow in the past year.
  • MD had negative earnings in each of the past 5 years.
  • MD had a negative operating cash flow in each of the past 5 years.
MD.CA Yearly Net Income VS EBIT VS OCF VS FCFMD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • The Return On Assets of MD (-4.07%) is better than 73.10% of its industry peers.
  • The Return On Equity of MD (-4.26%) is better than 75.34% of its industry peers.
Industry RankSector Rank
ROA -4.07%
ROE -4.26%
ROIC N/A
ROA(3y)-3.98%
ROA(5y)-3.87%
ROE(3y)-4.17%
ROE(5y)-4.03%
ROIC(3y)N/A
ROIC(5y)N/A
MD.CA Yearly ROA, ROE, ROICMD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MD.CA Yearly Profit, Operating, Gross MarginsMD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MD.CA Health Analysis

2.1 Basic Checks

  • MD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MD has been increased compared to 1 year ago.
  • Compared to 5 years ago, MD has more shares outstanding
  • MD has a worse debt/assets ratio than last year.
MD.CA Yearly Shares OutstandingMD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MD.CA Yearly Total Debt VS Total AssetsMD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • MD has an Altman-Z score of 13.15. This indicates that MD is financially healthy and has little risk of bankruptcy at the moment.
  • MD's Altman-Z score of 13.15 is fine compared to the rest of the industry. MD outperforms 66.75% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that MD is not too dependend on debt financing.
  • MD's Debt to Equity ratio of 0.00 is in line compared to the rest of the industry. MD outperforms 48.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.15
ROIC/WACCN/A
WACC12.07%
MD.CA Yearly LT Debt VS Equity VS FCFMD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M

2.3 Liquidity

  • MD has a Current Ratio of 5.91. This indicates that MD is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of MD (5.91) is better than 72.48% of its industry peers.
  • MD has a Quick Ratio of 5.91. This indicates that MD is financially healthy and has no problem in meeting its short term obligations.
  • MD's Quick ratio of 5.91 is fine compared to the rest of the industry. MD outperforms 72.60% of its industry peers.
Industry RankSector Rank
Current Ratio 5.91
Quick Ratio 5.91
MD.CA Yearly Current Assets VS Current LiabilitesMD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MD.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.87% over the past year.
  • The Revenue has grown by 120.05% in the past year. This is a very strong growth!
  • Measured over the past years, MD shows a very strong growth in Revenue. The Revenue has been growing by 47.20% on average per year.
EPS 1Y (TTM)25.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.9%
Revenue 1Y (TTM)120.05%
Revenue growth 3Y-7.88%
Revenue growth 5Y47.2%
Sales Q2Q%3824.07%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MD.CA Yearly Revenue VS EstimatesMD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100K 200K 300K

More info and screens

Find the best growth stocksShow best growing peers

0

4. MD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MD.CA Price Earnings VS Forward Price EarningsMD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MD.CA Per share dataMD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MD.CA Dividend Analysis

5.1 Amount

  • MD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MD.CA Fundamentals: All Metrics, Ratios and Statistics

MIDLAND EXPLORATION INC

TSX-V:MD (4/30/2026, 7:00:00 PM)

0.43

+0.02 (+4.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry Strength81.1
Industry Growth11.94
Earnings (Last)02-12
Earnings (Next)05-08
Inst Owners8.38%
Inst Owner ChangeN/A
Ins Owners4.25%
Ins Owner ChangeN/A
Market Cap48.58M
Revenue(TTM)371.00K
Net Income(TTM)-1.97M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 130.94
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -4.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.98%
ROA(5y)-3.87%
ROE(3y)-4.17%
ROE(5y)-4.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12940.2%
Cap/Sales 1067.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.91
Quick Ratio 5.91
Altman-Z 13.15
F-Score4
WACC12.07%
ROIC/WACCN/A
Cap/Depr(3y)11608%
Cap/Depr(5y)13524.1%
Cap/Sales(3y)1608.82%
Cap/Sales(5y)1919.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)120.05%
Revenue growth 3Y-7.88%
Revenue growth 5Y47.2%
Sales Q2Q%3824.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-213.09%
OCF growth 3YN/A
OCF growth 5YN/A

MIDLAND EXPLORATION INC / MD.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MIDLAND EXPLORATION INC (MD.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MD.CA.


Can you provide the valuation status for MIDLAND EXPLORATION INC?

ChartMill assigns a valuation rating of 0 / 10 to MIDLAND EXPLORATION INC (MD.CA). This can be considered as Overvalued.


Can you provide the profitability details for MIDLAND EXPLORATION INC?

MIDLAND EXPLORATION INC (MD.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for MD stock?

The financial health rating of MIDLAND EXPLORATION INC (MD.CA) is 5 / 10.